Close Menu
Home » Quidel

Quidel

Jan 16, 2020

JP Morgan Healthcare Day 3: Exact Sciences, NanoString, Natera, Horizon, Accelerate Dx, GenMark, More

Exact Sciences CEO Kevin Conroy discussed the firm's pipeline and plans for 2020 and beyond, while NanoString CEO Brad Gray talked about the company's GeoMx digital spatial profiling technology, among other presentations Wednesday.

Jan 09, 2020

Quidel Reports Preliminary 14 Percent to 15 Percent Q4 Revenue Growth

Quidel said that it expects fourth quarter 2019 revenues to be in the range of $151 million to $152 million, which would eclipse analyst expectations.

Oct 31, 2019

Quidel Touts Product Pipeline Despite Revenue Headwinds

Premium

The firm plans to launch 10 new products next year, but analysts were cautious about Quidel's prospects moving forward.  

Oct 30, 2019

Quidel Q3 Revenues Rise 8 Percent, Beat Expectations

The firm saw a 36 percent increase in influenza product sales compared to the third quarter last year.

Oct 08, 2019

Serosep, Quidel Ink US Distribution Deal for GI Panel

The FDA-cleared panel includes tests for salmonella, Shiga toxin-producing Escherichia coli, Shigella, Campylobacter, and Cryptosporidium.

Sep 03, 2019

Q2 Results, Biotech Market Weakness Weigh on Stocks of Genomic Tools, MDx Firms in August

The index, which slightly underperformed the Dow Jones, had a smaller loss in August than in the previous month.

Aug 09, 2019

Quidel Updates Dx and MDx Commercial Strategies, Pipelines

Premium

The company said it is pushing to begin simultaneous clinical trials for multiple small panel-based tests for its sample-to-answer Savanna platform.

Aug 08, 2019

Quidel Q2 Revenues Up 5 Percent on Rapid Immunoassay Business

The firm experienced a 30 percent jump in sales of immunoassays, attributed in part to a $6.2 million increase in influenza revenues year-over-year.

Aug 05, 2019

Molecular Testing for Flu Catching up, But Still Lagging Far Behind RIDTs

Premium

In US influenza testing, providers see growth in placements within hospital emergency departments, physicians' offices, urgent care centers, and retail clinics.

May 08, 2019

Quidel Q1 Revenues Fall 13 Percent on Tough Flu Comp, Currency Headwind

Flu test sales were the second-highest for a quarter in the firm's history but were still $17.4 million lower than the year-ago quarter due to a much less intense flu season.

Pages

The Scan

Hundreds and Hundreds Retracted

The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.

Guilty Plea in Kickback Case

The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.

Florida Bill Moves Ahead

News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.

Science Presents Studies Into Disease-Causing Mutations Among Bone Marrow Donors; Links Between Heavy Drinking, Other Disease

In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.

What's Popular?

In Quidel

  1. JP Morgan Healthcare Day 3: Exact Sciences, NanoString, Natera, Horizon, Accelerate Dx, GenMark, More

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.